Canadian Firm Explores Potential Of Nasal Spray In COVID-19 Prevention

 
• By Anju Ghangurde

Dr Gilly Regev, CEO of the anti-infectives-focused firm, SaNOtize Research & Development Corp, remains confident of the effectiveness of the firm’s nitric oxide nasal spray against evolving variants of SARS-CoV-2 and expects to progress plans for a “prevention” trial in the US.

SaNOtize Sees Potential For Nasal Spray In COVID-19 Prevention • Source: Shutterstock

More from R&D

More from Scrip